Differentiating vasculitis from other diseases: Difference between revisions

	Vasculitis
Overview
Classification Large-sized vessel vasculitis Takayasu's Arteritis Temporal Arteritis Medium-sized vessel vasculitis Kawasaki's Disease Polyarteritis Nodosa Small-sized vessel vasculitis Churg-Strauss Syndrome Cutaneous leukocytoclastic vasculitis Essential cryoglobulinemic vasculitis Henoch-Schonlein Purpura Microscopic polyangiitis Wegener's Granulomatosis Variable-sized vessel vasculitis Sjogren syndrome Cogan syndrome Single organ vasculitis Primary central nervous system angiitis
Causes
Differential Diagnosis

← Older edit Newer edit →

VisualWikitext

Revision as of 20:35, 29 March 2018

gsEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Differential Diagnosis

Abbreviations: ABG= Arterial blood gas, ANP= Atrial natriuretic peptide, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure.

			Symptoms					Physical examination			Lab Findings				Imaging				Histopathology
Diseases			Clinical manifestations								Para-clinical findings									Gold standard	Additional findings
			Symptoms					Physical examination			Para-clinical findings
			Headache	Fever	Weight loss	Arthralgia	Claudication	Bruit	HTN	Focal neurological disorder	Biomarker	CBC	ESR	Other	CT scan	Angiography	Ultrasound	Other	Histopathology
Large-Vessel Vasculitis	Takayasu arteritis^[1]		+	+/-	+	-	+	+	+/-	+/-	MMP-3 and MMP-9	Leukocytosis, Anemia	↑	↑CRP	Aneurysmal dilatation of the aorta	Blood vessel stenosis	Circumferential thickening of the arterial wall (Macaroni sign)	PET-scan, Cardiac CT	Granulomatous inflammation of arteries	Arteriography	Coronary aneurysm
	Giant cell arteritis^[2]		+	-	+	+/-	-	-	-	+/-	Pentraxin 3 (PTX3)	Normal	↑	↑CRP	Stenosis, Occlusion, Dilatation	Aneurysm	-	Mural inflammation in MRA	Granulomatous inflammation of arteries	Biopsy	Jaw pain and claudication
	Neurological disease	Cerebral aneurysm^[3]	+	-	-	-	-	-	+/-	+	-	Normal	Normal	-	Well-defined round, slightly hyperattenuating lesion	Bulging out of the main lumen	-	Heterogeneous signal intensity in MRA	Layers of smooth muscle cells, Intact endothelium	Digital subtraction angiography (DSA)	Nausea, Vomiting
		Neurofibromatosis type 1^[4]	+/-	-	+/-	-	-	-	+	+	NF1 mutated gene	Normal	Normal	Neurofibromin gene	Bone abnormalities	Optical coherence tomography angiography (OCTA)	-	Optic nerve gliomas in MRI	Elongated spindle-shaped cells in neurofibromas	NIH diagnostic criteria	Cafe au Lait spot
		Neurofibromatosis type 2^[5]	+/-	-	+/-	-	+/-	-	-	+	NF2 mutated gene	Normal	Normal	Schwannomin	Meningioma, Schwannoma, Ependymoma	Fluorescein angiography showed retinal hamartoma	Localized schwannomas in nerve ultrasound	Schwannoma in MRI	Encapsulated biphasic nerve sheath tumor	NIH diagnostic criteria	Hearing loss, Vision loss
	Systemic disease	Fibromuscular dysplasia^[6]	+	-	+/-	+	+	+	+	+/-	Transforming growth factor β (TGF-β)	Normal	↑	↑ Cr or BUN	Alternating stenosis and dilatations in CT angiography	Stenosis in the renal arteries	Luminal narrowing alternating with dilatation (Beads sign)	Focal concentric, long-segment tubular stenosis or outpouching in MRA	Fibrodysplastic changes, Collagen deposition	Digital subtraction angiography (DSA)	Spontaneous coronary artery dissection (SCAD)
		Ehlers-Danlos syndrome^[7]	-	-	-	+	+/-	+/-	-	+/-	TGF-β	Normal	Normal	Cultured skin fibroblasts	Multiple vascular segments with aneurysms and dissections	Dissection of the posterolateral branch of the left circumflex coronary artery (LCx)	Visceral arteries abnormality	Vascular abnormalities in MRA	Thin and rare collagen bundles in the dermis	History and physical examination	Bleeding, Bruisability, Heart murmur
		Polymyalgia rheumatica (PMR)^[8]	+	-	+/-	+	-	-	-	-	Plasma fibrinogen	Normocytic, normochromic anemia	↑	CRP	Periodontoid localization of calcification	Vessel wall thickening, Increased mural contrast enhancement	Subacromial or subdeltoid bursitis	High F-FDG accumulation around the joints in FDG PET-CT	Small angular fibers, Pyknotic nuclear clumps, or target-targetoid fibers	-	Joint stiffness, Fatigue
		Amyloidosis^[9]	+/-	-	-	+/-	+/-	-	+	+	Immunoglobulin light chain (Amyloid)	Anemia	Normal	↑ Cr or BUN, ↑ ALT or AST	Diffusely hypoattenuating and enlarged liver	Amyloid deposition in the media and adventitia of small arteries	Solid organs increased echogenicity	Tc-DPD for cardiac amyloid deposits	Extracellular deposition of fibrillar proteins	Biopsy	Cardiomegaly, Dyspnea
Diseases			Headache	Fever	Weight loss	Arthralgia	Claudication	Bruit	HTN	Focal neurological disorder	Biomarker	CBC	ESR	Other	CT scan	Angiography	Ultrasound	Other	Histopathology	Gold standard	Additional findings
Medium-Vessel Vasculitis	Polyarteritis nodosa^[10]		+	+	+	+	+	+	+/-	+/-	LAMP-2 protein autoantibodies	Leukocytosis, Normochromic anemia, Thrombocytosis	↑	↑ Cr or BUN, ↑ ALT or AST, Proteinuria	Focal regions of infarction or hemorrhage	Multiple microaneurysms, Hemorrhage due to focal rupture, Occlusion	Aneurysms and renal arteriovenous fistula in color Doppler sonography	-	Necrotizing inflammatory lesions	Angiography	Sudden weight loss, Abdominal pain
	Hepatitis B virus-associated polyarteritis nodosa^[11]		+/-	+/-	+	+	+/-	+/-	+	-	HBsAg	Leukocytosis, Normochromic anemia, Thrombocytosis	↑	↑ ALT or AST	Focal regions of infarction or hemorrhage	Microaneurysms in mesenteric artery	Aneurysms and renal arteriovenous fistula in color Doppler sonography	-	Necrotizing inflammatory lesions	Angiography	Peripheral neuropathy, Livedo reticularis
	Kawasaki disease^[12]		-	+	+/-	+	+	-	+/-	-	NT-proBNP, Meprin A, Filamin C	Normochromic anemia, ↑WBC with a left shift, Thrombocytosis	↑	Acute-phase reactants, ↓Cholesterol, ↓HDL, ↓ApolipoA	Coronary artery calcifications	Coronary artery aneurysms, stenosis or occlusion	Coronary artery anomaly in echocardiography	Electron beam CT (EBCT)	Acute destruction of the media by neutrophils, with loss of elastic fibers	History and physical examination	Diarrhea, Vomiting
	Infectious disease	Parvovirus B19 infection^[13]	+	+	+	+	-	-	-	+/-	B19 DNA, ↓Reticulocyte count	Anemia	↑	anti–parvovirus B19 IgM	-	-	Hydrops in fetal ultrasonography	-	-	B19 DNA	Purpuric rash, Erythema multiforme
		Scarlet fever^[14]	+	+	+/-	+	-	-	-	-	Antistreptolysin-O (ASO) titers	Leukocytosis	↑	↑CRP	Thickened pulmonary markings if pneumonia	-	-	-	Sparse neutrophilic perivascular infiltrate	History and physical examination	Sand-paper rashes, Sore throat
		Toxic shock syndrome^[15]	+	+	+	+	-	-	-	+/-	Procalcitonin	Leukocytosis with left shift	↑	Myoglobinuria, Sterile pyuria	Acute respiratory distress syndrome	-	-	-	Necrolysis of keratinocytes in epidermis, Perivascular lymphocytic infiltrate	Clinical criteria	Peeling or rashes, Organ dysfunction
		Mononucleosis^[16]	+	+	+	+	-	-	-	-	EBV DNA	Atypical lymphocyte	↑	Heterophile antibodies	CNS involvement	-	Splenomegaly	Encephalitis in MRI	Lymphoproliferative response in oropharynx, Lymphocytic infiltration in spleen	Heterophile antibody test	Splenomegaly, Palatal petechiae
		Leptospirosis^[17]	+	+	+	+	+/-	-	-	-	IL-6, IL-8 and IL-10	Anemia	-	↑Cr or BUN, ↑ALT or AST, Proteinuria	Diffuse alveolar hemorrhage	-	-	-	Toxin-mediated break down of endothelial cell membranes of capillaries	Culture and the microscopic agglutination test	Red eyes, Skin rash
		Lyme Disease^[18]	+/-	+	+/-	+	+/-	-	-	-	CXCL9 (MIG), CXCL10 (IP-10) and CCL19 (MIP3B)	Leukopenia, Thrombocytopenia	-	Microscopic hematuria, Proteinuria, ↑ALT or AST	Punctate lesions in periventricular white matter in brain SPECT	-	-	-	Acrodermatitis chronica atrophicans	Serologic tests	Erythema migrans
		Measles^[19]	+/-	+	+/-	+	-	-	-	-	Measles IgM	Leukopenia, Lymphocytosis, Thrombocytopenia	-	↑ALT or AST	Pneumonia	-	-	CXR	Spongiosis and vesiculation in the epidermis with scattered dyskeratotic keratinocytes	PCR	Generalized rash, Cough, Coryza, or Conjunctivitis
		Rocky Mountain Spotted Fever^[20]	+	+	+	+	-	-	-	-	R rickettsii serology	Thrombocytopenia, Anemia	-	↑ALT or AST, Hyponatremia	Infarction, edema, and meningeal enhancement	-	Myocardial or conduction abnormalities in echocardiography	-	Immunofluorescent or immunoperoxidase staining of R rickettsii	Clinical criteria and tick exposure	Rash on the palms and soles
		Staphylococcal Scalded Skin Syndrome^[21]	+	+	+	+	-	-	+/-	+/-	Anti exfoliatin and anti alpha-toxin antibodies	Leukocytosis with left shift	↑	Blood culture	Pneumonia	-	-	-	Intraepidermal blister, dense superficial perivascular lymphohistiocytic infiltrate	Blood culture and clinical findings	Widespread skin erythema, fluid-filled blisters
		Toxic Epidermal Necrolysis^[22]	-	+	+	-	-	-	-	+/-	MicroRNA-124	Normochromic normocytic anemia, Eosinophilia	↑	Fluid loss and electrolyte abnormalities	Tracheobronchial inflammation	-	-	-	Necrotic keratinocytes with full-thickness epithelial necrosis	Histopathology and clinical findings	Erythematous macular rash with purpuric centers
	Cardiovascular disease	Atrial Myxoma^[23]	-	-	+/-	-	-	-	-	+/-	Calretinin	Mild anemia, Leukocytosis	↑	↑IL-6	Atrial filling defect larger than a thrombus	-	Tumor location, size, attachment, and mobility in echocardiography	Size, shape, and surface characteristics in MRI	Lipidic cells embedded in a vascular myxoid stroma	Echocardiography	Dyspnea on exertion, Syncope
		Cholesterol Embolism^[24]	+/-	+/-	-	-	+	-	-	+	IL-5	Eosinophilia, Leukocytosis	↑	Eosinophiluria	Thoracic and abdominal aortic sources of embolism	Atheroembolism in abdominal aorta and the lower extremity arteries	Excluding an intracardiac source of embolism with echocardiography	-	Birefringent crystals or biconvex needle-shaped ghostly clefts within the arterial lumen	Angiography	Livedo reticularis, Ischemic patches
		Segmental arterial mediolysis^[25]	+	-	-	-	+	+	+	+/-	-	Leukocytosis	-	-	Visceral artery aneurysm in CT angiography	Alternating aneurysms and stenoses (beading)	Retroperitoneal hematoma	-	Disruption of the smooth muscle in the media	Angiography	Hematuria, Ischemic colitis
	Systemic disease	Antiphospholipid Syndrome^[26]	+	+	-	-	-	-	-	+/-	Antiphospholipid antibodies	Thrombocytopenia, Hemolytic anemia	-	Lupus anticoagulant (LA)	Stroke, Pulmonary embolism, Budd-Chiari syndrome	Thrombus in major vessels	Valve thickening, vegetations, or insufficiency in echocardiography	-	Noninflammatory bland thrombosis without perivascular inflammation	Hx of thrombosis and antiphospholipid antibodies	Miscarriage, Pulmonary hypertension
	Systemic disease	Juvenile Idiopathic Arthritis^[27]	-	-	-	+	+/-	-	-	-	Rheumatoid factor (RF), S100A12	Lymphocytosis, Thrombocytopenia	↑	Myeloid-related proteins 8/14 (MRP8/14)	Synovial hypertrophy, Joint effusions	Cerebral vasculitis	Inflamed synovium	Bone scanning	Vascular congestion, RBC extravasation, Venular lumen occlusion	Conventional radiography	Evanescent rash, Dactylitis
Diseases			Headache	Fever	Weight loss	Arthralgia	Claudication	Bruit	HTN	Focal neurological disorder	Biomarker	CBC	ESR	Other	CT scan	Angiography	Ultrasound	Other	Histopathology	Gold standard	Additional findings
Small-Vessel Vasculitis	ANCA-associated vasculitis	Microscopic polyangiitis	+	-	-	+/-	-	-	-	+	Anti-PR3 antibody, Anti-MPO antibody
		Granulomatosis with polyangiitis (Wegener’s)	+	+/-	+/-	-	-	-	-	+	Anti-PR3 antibody, Anti-MPO antibody
		Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)	+/-	-	-	+	-	-	-	+	Eotaxin-3
		Hydralazine-associated ANCA-associated vasculitis	-	-	-	+	-	-	-	+/-
	Immune complex small-vessel vasculitis	Anti-glomerular basement membrane disease	-	+/-	-	-	-	-	+	-
		Cryoglobulinemic vasculitis	+/-	+/-	-	+	+/-	-	-	-	C4 component
		Hepatitis C virus-associated cryoglobulinemic vasculitis	+/-	+/-	+	+	-	-	+	+/-	HCV RNA			↓Serum C4, Positive RF							Palpable purpura, Microscopic hematuria
		IgA vasculitis (Henoch-Schönlein purpura)	-	-	+	+	-	-	-	-											Hematuria
		Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)	-	-	+/-	+	-	-	-	-
	Gastrointestinal disease	Acute mesenteric ischemia	-	+/-	-	-	-	-	-	-
	Cardiovascular disease	Infective Endocarditis	+	+	+	-	-	-	-	+
	Cardiovascular disease	Leukocytoclastic Vasculitis	+	-	-	+	-	-	-	+
	Pulmonary disease	Langerhans Cell Histiocytosis	+/-	-	-	+	-	-	-	-
		Lung Abscess	-	+	+	-	-	-	-	-
		Non-Small Cell Lung Cancer	-	+/-	+	-	-	-	-	+/-
		Small Cell Lung Cancer	-	+/-	+	-	-	-	-	+/-
		Asthma	-	+	+	-	-	-	-	-
		Pulmonary Infarction	+/-	-	-	-	-	-	+	-
	Renal disease	Acute Poststreptococcal Glomerulonephritis	-	-	-	+	-	-	+	+/-
	Hematologic disease	Hemolytic-Uremic Syndrome	+	+	-	+	-	-	+	+
		Chronic Lymphocytic Leukemia (CLL)	+	+	+	+	+/-	-	-	+/-
		Multiple Myeloma	+	-	+	+	+	+	+/-	+/-
		Hypereosinophilic Syndrome	+/-	+/-	-	-	-	-	-	-
		Non-Hodgkin Lymphoma	+	+	+	+	+/-	+/-	+/-	+/-
		Serum Sickness	+	+	-	+/-	+/-	-	-	+/-
		Disseminated Intravascular Coagulation	+/-	+	-	+/-	-	-	+	+
		Idiopathic Thrombocytopenic Purpura	+	+/-	-	+	-	-	-	+
		B cell lymphoproliferative disorder	+	+	+	+	+/-	-	-	+
	Systemic disease	Sarcoidosis	+	+	+	+	-	-	-	+/-
		Legionella Infection	+	+	+	+	-	-	-	+/-
		Systemic lupus erythematosus	+	+	+	+	-	-	+	+
		Rheumatoid arthritis	-	-	+	+	+	+	-	-
		Relapsing polychondritis	-	+/-	+/-	+	+	-	-	-
Diseases			Headache	Fever	Weight loss	Arthralgia	Claudication	Bruit	HTN	Focal neurological disorder	Biomarker	CBC	ESR	Other	CT scan	Angiography	Ultrasound	Other	Histopathology	Gold standard	Additional findings
Variable-vessel vasculitis	Behçet’s syndrome		-	-	-	+	-	-	+/-	-
	Cogan's syndrome		+/-	-	-	+/-	-	-	-	+											Red eye, Hearing loss, Vertigo
	Gastrointestinal disease	Inflammatory Bowel Disease	+/-	+	+	+	+	-	-	-
		Whipple's disease	+	+/-	+	+	+	+	+	+
		Sjögren's syndrome	-	-	+/-	+	-	-	-	-
Single-organ vasculitis	Primary central nervous system vasculitis		+	+	+	-	+	-	+	+	von Willebrand factor antigen (vWF)
	Infectious disease	Aspergillosis	+	+	+	-	-	-	-	+
		Histoplasmosis	+	+	+	+	+	-	-	+
		Herpes Simplex Encephalitis	+	+	-	-	-	-	-	+
	Systemic disease	Eclampsia	+	+	-	+	-	-	+	+
	Systemic disease	Fibromuscular dysplasia^[6]	+	-	+/-	+	+	+	+	+/-	Transforming growth factor β (TGF-β)	Normal	↑	↑ Cr or BUN	Alternating stenosis and dilatations in CT angiography	Stenosis in the renal arteries	Luminal narrowing alternating with dilatation (Beads sign)	Focal concentric, long-segment tubular stenosis or outpouching in MRA	Fibrodysplastic changes, Collagen deposition	Digital subtraction angiography (DSA)	Spontaneous coronary artery dissection (SCAD)

References

↑ Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.
↑ Calvo-Romero JM (2003). "Giant cell arteritis". Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.
↑ Stafa A, Leonardi M (2008). "Role of neuroradiology in evaluating cerebral aneurysms". Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.
↑ Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). "Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1". Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.
↑ Evans, D G. R (2000). "Neurofibromatosis type 2". Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.
↑ ^6.0 ^6.1 Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). "Fibromuscular dysplasia". Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.
↑ Gazit Y, Jacob G, Grahame R (2016). "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder". Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.
↑ Michet CJ, Matteson EL (2008). "Polymyalgia rheumatica". BMJ. 336 (7647): 765–9. doi:10.1136/bmj.39514.653588.80. PMC 2287267. PMID 18390527.
↑ Baker KR, Rice L (2012). "The amyloidoses: clinical features, diagnosis and treatment". Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.
↑ Howard T, Ahmad K, Swanson JA, Misra S (2014). "Polyarteritis nodosa". Tech Vasc Interv Radiol. 17 (4): 247–51. doi:10.1053/j.tvir.2014.11.005. PMC 4363102. PMID 25770638.
↑ Sharma A, Sharma K (September 2013). "Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis". J Clin Exp Hepatol. 3 (3): 204–12. doi:10.1016/j.jceh.2013.06.001. PMC 4216827. PMID 25755502.
↑ Takahashi K, Oharaseki T, Yokouchi Y (2011). "Pathogenesis of Kawasaki disease". Clin Exp Immunol. 164 Suppl 1: 20–2. doi:10.1111/j.1365-2249.2011.04361.x. PMC 3095860. PMID 21447126.
↑ Heegaard ED, Brown KE (2002). "Human parvovirus B19". Clin Microbiol Rev. 15 (3): 485–505. PMC 118081. PMID 12097253.
↑ Basetti S, Hodgson J, Rawson TM, Majeed A (2017). "Scarlet fever: a guide for general practitioners". London J Prim Care (Abingdon). 9 (5): 77–79. doi:10.1080/17571472.2017.1365677. PMC 5649319. PMID 29081840.
↑ Vostral SL (2011). "Rely and Toxic Shock Syndrome: a technological health crisis". Yale J Biol Med. 84 (4): 447–59. PMC 3238331. PMID 22180682.
↑ Balfour HH, Dunmire SK, Hogquist KA (2015). "Infectious mononucleosis". Clin Transl Immunology. 4 (2): e33. doi:10.1038/cti.2015.1. PMC 4346501. PMID 25774295.
↑ Levett PN (April 2001). "Leptospirosis". Clin. Microbiol. Rev. 14 (2): 296–326. doi:10.1128/CMR.14.2.296-326.2001. PMC 88975. PMID 11292640.
↑ Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T (2012). "Lyme disease: review". Arch Med Sci. 8 (6): 978–82. doi:10.5114/aoms.2012.30948. PMC 3542482. PMID 23319969.
↑ White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012). "Measles, mumps, and rubella". Clin Obstet Gynecol. 55 (2): 550–9. doi:10.1097/GRF.0b013e31824df256. PMC 3334858. PMID 22510638.
↑ Walker DH (1989). "Rocky Mountain spotted fever: a disease in need of microbiological concern". Clin Microbiol Rev. 2 (3): 227–40. PMC 358117. PMID 2504480.
↑ Mishra AK, Yadav P, Mishra A (2016). "A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates". Open Microbiol J. 10: 150–9. doi:10.2174/1874285801610010150. PMC 5012080. PMID 27651848.
↑ Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E; et al. (2016). "Toxic epidermal necrolysis". F1000Res. 5. doi:10.12688/f1000research.7574.1. PMC 4879934. PMID 27239294.
↑ MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E (June 1993). "Atrial myxoma: national incidence, diagnosis and surgical management". Ir J Med Sci. 162 (6): 223–6. PMID 8407260.
↑ Avci G, Akoz T, Gul AE (2009). "Cutaneous cholesterol embolization". J Dermatol Case Rep. 3 (2): 27–9. doi:10.3315/jdcr.2009.1031. PMC 3157794. PMID 21886725.
↑ Chao, Christine (2009). "Segmental Arterial Mediolysis". Seminars in Interventional Radiology. 26 (03): 224–232. doi:10.1055/s-0029-1225666. ISSN 0739-9529.
↑ Chaturvedi S, McCrae KR (2015). "The antiphospholipid syndrome: still an enigma". Hematology Am Soc Hematol Educ Program. 2015: 53–60. doi:10.1182/asheducation-2015.1.53. PMC 4877624. PMID 26637701.
↑ Espinosa M, Gottlieb BS (July 2012). "Juvenile idiopathic arthritis". Pediatr Rev. 33 (7): 303–13. doi:10.1542/pir.33-7-303. PMID 22753788.

Template:WH Template:WS

[pmid23626437-1] Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.

[pmid13679546-2] Calvo-Romero JM (2003). "Giant cell arteritis". Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.

[pmid20557771-3] Stafa A, Leonardi M (2008). "Role of neuroradiology in evaluating cerebral aneurysms". Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.

[pmid28512424-4] Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). "Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1". Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.

[Evans2000-5] Evans, D G. R (2000). "Neurofibromatosis type 2". Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.

[pmid17555581-6] 6.0 ^6.1 Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). "Fibromuscular dysplasia". Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.

[pmid27824552-7] Gazit Y, Jacob G, Grahame R (2016). "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder". Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.

[pmid18390527-8] Michet CJ, Matteson EL (2008). "Polymyalgia rheumatica". BMJ. 336 (7647): 765–9. doi:10.1136/bmj.39514.653588.80. PMC 2287267. PMID 18390527.

[pmid23227278-9] Baker KR, Rice L (2012). "The amyloidoses: clinical features, diagnosis and treatment". Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.

[pmid25770638-10] Howard T, Ahmad K, Swanson JA, Misra S (2014). "Polyarteritis nodosa". Tech Vasc Interv Radiol. 17 (4): 247–51. doi:10.1053/j.tvir.2014.11.005. PMC 4363102. PMID 25770638.

[pmid25755502-11] Sharma A, Sharma K (September 2013). "Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis". J Clin Exp Hepatol. 3 (3): 204–12. doi:10.1016/j.jceh.2013.06.001. PMC 4216827. PMID 25755502.

[pmid21447126-12] Takahashi K, Oharaseki T, Yokouchi Y (2011). "Pathogenesis of Kawasaki disease". Clin Exp Immunol. 164 Suppl 1: 20–2. doi:10.1111/j.1365-2249.2011.04361.x. PMC 3095860. PMID 21447126.

[pmid12097253-13] Heegaard ED, Brown KE (2002). "Human parvovirus B19". Clin Microbiol Rev. 15 (3): 485–505. PMC 118081. PMID 12097253.

[pmid29081840-14] Basetti S, Hodgson J, Rawson TM, Majeed A (2017). "Scarlet fever: a guide for general practitioners". London J Prim Care (Abingdon). 9 (5): 77–79. doi:10.1080/17571472.2017.1365677. PMC 5649319. PMID 29081840.

[pmid22180682-15] Vostral SL (2011). "Rely and Toxic Shock Syndrome: a technological health crisis". Yale J Biol Med. 84 (4): 447–59. PMC 3238331. PMID 22180682.

[pmid25774295-16] Balfour HH, Dunmire SK, Hogquist KA (2015). "Infectious mononucleosis". Clin Transl Immunology. 4 (2): e33. doi:10.1038/cti.2015.1. PMC 4346501. PMID 25774295.

[pmid11292640-17] Levett PN (April 2001). "Leptospirosis". Clin. Microbiol. Rev. 14 (2): 296–326. doi:10.1128/CMR.14.2.296-326.2001. PMC 88975. PMID 11292640.

[pmid23319969-18] Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T (2012). "Lyme disease: review". Arch Med Sci. 8 (6): 978–82. doi:10.5114/aoms.2012.30948. PMC 3542482. PMID 23319969.

[pmid22510638-19] White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012). "Measles, mumps, and rubella". Clin Obstet Gynecol. 55 (2): 550–9. doi:10.1097/GRF.0b013e31824df256. PMC 3334858. PMID 22510638.

[pmid2504480-20] Walker DH (1989). "Rocky Mountain spotted fever: a disease in need of microbiological concern". Clin Microbiol Rev. 2 (3): 227–40. PMC 358117. PMID 2504480.

[pmid27651848-21] Mishra AK, Yadav P, Mishra A (2016). "A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates". Open Microbiol J. 10: 150–9. doi:10.2174/1874285801610010150. PMC 5012080. PMID 27651848.

[pmid27239294-22] Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E; et al. (2016). "Toxic epidermal necrolysis". F1000Res. 5. doi:10.12688/f1000research.7574.1. PMC 4879934. PMID 27239294.

[pmid8407260-23] MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E (June 1993). "Atrial myxoma: national incidence, diagnosis and surgical management". Ir J Med Sci. 162 (6): 223–6. PMID 8407260.

[pmid21886725-24] Avci G, Akoz T, Gul AE (2009). "Cutaneous cholesterol embolization". J Dermatol Case Rep. 3 (2): 27–9. doi:10.3315/jdcr.2009.1031. PMC 3157794. PMID 21886725.

[Chao2009-25] Chao, Christine (2009). "Segmental Arterial Mediolysis". Seminars in Interventional Radiology. 26 (03): 224–232. doi:10.1055/s-0029-1225666. ISSN 0739-9529.

[pmid26637701-26] Chaturvedi S, McCrae KR (2015). "The antiphospholipid syndrome: still an enigma". Hematology Am Soc Hematol Educ Program. 2015: 53–60. doi:10.1182/asheducation-2015.1.53. PMC 4877624. PMID 26637701.

[pmid22753788-27] Espinosa M, Gottlieb BS (July 2012). "Juvenile idiopathic arthritis". Pediatr Rev. 33 (7): 303–13. doi:10.1542/pir.33-7-303. PMID 22753788.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

@@ Line 52: / Line 52: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[ESR]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[MMP|MMP-3]] and [[Matrix metalloproteinase|MMP-9]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
@@ Line 73: / Line 73: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[ESR]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pentraxin|Pentraxin 3 (PTX3)]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
@@ Line 266: / Line 266: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[ESR]], [[CRP]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[LAMP2|LAMP-2 protein autoantibodies]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia]], [[Thrombocytosis]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
@@ Line 470: / Line 470: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rash|Generalized rash]], [[Cough]], [[Coryza]], or [[Conjunctivitis]]
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rocky Mountain Spotted Fever]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rocky Mountain Spotted Fever]]<ref name="pmid2504480">{{cite journal| author=Walker DH| title=Rocky Mountain spotted fever: a disease in need of microbiological concern. | journal=Clin Microbiol Rev | year= 1989 | volume= 2 | issue= 3 | pages= 227-40 | pmid=2504480 | doi= | pmc=358117 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2504480  }}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
@@ Line 486: / Line 486: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Myocardial]] or conduction abnormalities in [[echocardiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-!
+![[Immunofluorescent]] or [[immunoperoxidase]] staining of ''[[Rickettsia rickettsii infection|R rickettsii]]''
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical criteria and [[tick]] exposure
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Rash on the [[Palms of the hands|palms]] and [[soles]]
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Staphylococcal scalded skin syndrome|Staphylococcal Scalded Skin Syndrome]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Staphylococcal scalded skin syndrome|Staphylococcal Scalded Skin Syndrome]]<ref name="pmid27651848">{{cite journal| author=Mishra AK, Yadav P, Mishra A| title=A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. | journal=Open Microbiol J | year= 2016 | volume= 10 | issue=  | pages= 150-9 | pmid=27651848 | doi=10.2174/1874285801610010150 | pmc=5012080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27651848  }}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
@@ Line 500: / Line 500: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Anti exfoliatin and [[Alpha toxin|anti alpha-toxin antibodies]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] with [[left shift]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Blood culture]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pneumonia]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-!
+![[Epidermal bullosa simplex|Intraepidermal blister]], dense superficial perivascular lymphohistiocytic infiltrate
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Blood culture]] and clinical findings
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Erythroderma|'''Widespread''' skin erythema]], [[Blisters|fluid-filled '''blisters''']]
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic Epidermal Necrolysis]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic Epidermal Necrolysis]]<ref name="pmid27239294">{{cite journal| author=Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E et al.| title=Toxic epidermal necrolysis. | journal=F1000Res | year= 2016 | volume= 5 | issue=  | pages=  | pmid=27239294 | doi=10.12688/f1000research.7574.1 | pmc=4879934 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27239294  }}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
@@ Line 521: / Line 521: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[MicroRNA|MicroRNA-124]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Normocytic normochromic anemia|Normochromic normocytic anemia]], [[Eosinophilia]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Fluid loss]] and [[electrolyte abnormalities]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Tracheobronchial]] [[inflammation]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-!
+![[Necrotic]] [[keratinocytes]] with full-thickness [[epithelial]] [[necrosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology]] and clinical findings
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Erythematous rash|Erythematous macular rash]] with [[purpuric]] centers
 |-
 ! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Atrial Myxoma]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Atrial Myxoma]]<ref name="pmid8407260">{{cite journal |vauthors=MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E |title=Atrial myxoma: national incidence, diagnosis and surgical management |journal=Ir J Med Sci |volume=162 |issue=6 |pages=223–6 |date=June 1993 |pmid=8407260 |doi= |url=}}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
@@ Line 543: / Line 543: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Calretinin]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mild [[anemia]], [[Leukocytosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Interleukin 6|IL-6]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Atrial]] filling defect larger than a [[thrombus]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Tumor]] location, size, attachment, and mobility in [[echocardiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Size, shape, and surface characteristics in [[MRI]]
-!
+![[Lipid|Lipidic]] cells embedded in a [[vascular]] myxoid stroma
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Echocardiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Dyspnea on exertion]], [[Syncope]]
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholesterol Embolism]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholesterol Embolism]]<ref name="pmid21886725">{{cite journal| author=Avci G, Akoz T, Gul AE| title=Cutaneous cholesterol embolization. | journal=J Dermatol Case Rep | year= 2009 | volume= 3 | issue= 2 | pages= 27-9 | pmid=21886725 | doi=10.3315/jdcr.2009.1031 | pmc=3157794 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21886725  }}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
@@ Line 564: / Line 564: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interleukin 5|IL-5]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]], [[Leukocytosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophiluria]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thoracic aorta|Thoracic]] and [[Abdominal aorta|abdominal aortic]] sources of [[embolism]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Atheroembolism]] in [[abdominal aorta]] and the [[lower extremity]] [[arteries]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Excluding an [[intracardiac]] source of [[embolism]] with [[echocardiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-!
+![[Birefringent]] crystals or biconvex needle-shaped ghostly clefts within the [[arterial]] [[lumen]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Angiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Livedo reticularis]],
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Segmental arteries|Segmental arterial]] mediolysis
+[[Ischemic|Ischemic patches]]
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Segmental arteries|Segmental arterial]] mediolysis<ref name="Chao2009">{{cite journal|last1=Chao|first1=Christine|title=Segmental Arterial Mediolysis|journal=Seminars in Interventional Radiology|volume=26|issue=03|year=2009|pages=224–232|issn=0739-9529|doi=10.1055/s-0029-1225666}}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
@@ Line 585: / Line 587: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Visceral]] artery [[aneurysm]] in [[CT angiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Alternating [[aneurysms]] and [[stenoses]] (beading)
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Retroperitoneal hematoma]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-!
+!Disruption of the [[smooth muscle]] in the [[Tunica media|media]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Angiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Ischemic colitis]]
 |-
 ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Antiphospholipid syndrome|Antiphospholipid Syndrome]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Antiphospholipid syndrome|Antiphospholipid Syndrome]]<ref name="pmid26637701">{{cite journal| author=Chaturvedi S, McCrae KR| title=The antiphospholipid syndrome: still an enigma. | journal=Hematology Am Soc Hematol Educ Program | year= 2015 | volume= 2015 | issue=  | pages= 53-60 | pmid=26637701 | doi=10.1182/asheducation-2015.1.53 | pmc=4877624 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26637701  }}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
@@ Line 607: / Line 609: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antiphospholipid antibodies]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombocytopenia]], [[Hemolytic anemia]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lupus anticoagulant|Lupus anticoagulant (LA)]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stroke]],
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+[[Pulmonary embolism]], [[Budd-Chiari syndrome]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombus]] in major [[vessels]]
-!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Valve thickening, vegetations, or  insufficiency in [[echocardiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!Noninflammatory bland [[thrombosis]] without perivascular [[inflammation]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hx of [[thrombosis]] and [[antiphospholipid antibodies]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Miscarriage]], [[Pulmonary hypertension]]
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Juvenile Idiopathic Arthritis]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Juvenile Idiopathic Arthritis]]<ref name="pmid22753788">{{cite journal |vauthors=Espinosa M, Gottlieb BS |title=Juvenile idiopathic arthritis |journal=Pediatr Rev |volume=33 |issue=7 |pages=303–13 |date=July 2012 |pmid=22753788 |doi=10.1542/pir.33-7-303 |url=}}</ref>
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
@@ Line 628: / Line 632: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rheumatoid factor|Rheumatoid factor (RF)]], [[S100A12]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphocytosis]], [[Thrombocytopenia]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Myeloid-related proteins 8/14 (MRP8/14)
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Synovial]] [[hypertrophy]], Joint effusions
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cerebral vasculitis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Inflamed [[synovium]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bone scan|Bone scanning]]
-!
+![[Vascular congestion]], [[Extravasation|RBC extravasation]], Venular lumen occlusion
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Conventional [[radiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rash|Evanescent rash]], [[Dactylitis]]
 |-
 ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases
@@ Line 664: / Line 668: @@
 ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]]
 ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Microscopic polyangiitis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Anti-PR3 [[antibody]], [[MPO|Anti-MPO]] [[antibody]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 685: / Line 689: @@
 |-
 ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Anti-PR3 [[antibody]], [[MPO|Anti-MPO]] [[antibody]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 692: / Line 705: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Eotaxin-3
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 705: / Line 730: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hydralazine]]-associated [[ANCA-associated vasculitis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 717: / Line 747: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hydralazine]]-associated [[ANCA-associated vasculitis]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 734: / Line 769: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C4A|C4 component]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 747: / Line 794: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis C|HCV RNA]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C4A|Serum C4]], Positive [[RF]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Palpable [[purpura]], [[Microscopic hematuria]]
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Henoch-Schönlein purpura|IgA vasculitis (Henoch-Schönlein purpura)]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 767: / Line 834: @@
 !
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]]
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypocomplementemia|Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 778: / Line 853: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute mesenteric ischemia]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 790: / Line 879: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]
+! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infective Endocarditis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C4A|serum C4]], Positive [[RF]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 809: / Line 899: @@
 !
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Palpable [[purpura]], [[Microscopic hematuria]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Henoch-Schönlein purpura|IgA vasculitis (Henoch-Schönlein purpura)]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Leukocytoclastic vasculitis|Leukocytoclastic Vasculitis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 832: / Line 922: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypocomplementemia|Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)]]
+! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Langerhans Cell Histiocytosis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 841: / Line 940: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Lung abscess|Lung Abscess]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 853: / Line 965: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute mesenteric ischemia]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 875: / Line 986: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Small cell lung cancer|Small Cell Lung Cancer]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infective Endocarditis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 886: / Line 1,003: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Asthma]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 893: / Line 1,021: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Leukocytoclastic vasculitis|Leukocytoclastic Vasculitis]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary Infarction]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 910: / Line 1,045: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute poststreptococcal glomerulonephritis|Acute Poststreptococcal Glomerulonephritis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Langerhans Cell Histiocytosis]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 926: / Line 1,067: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! rowspan="9" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hematologic disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 940: / Line 1,093: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Lung abscess|Lung Abscess]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia (CLL)]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 949: / Line 1,110: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Multiple myeloma|Multiple Myeloma]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 961: / Line 1,135: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypereosinophilic syndrome|Hypereosinophilic Syndrome]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 982: / Line 1,156: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Small cell lung cancer|Small Cell Lung Cancer]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 992: / Line 1,173: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Serum sickness|Serum Sickness]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 999: / Line 1,191: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Asthma]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,016: / Line 1,215: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Idiopathic thrombocytopenic purpura|Idiopathic Thrombocytopenic Purpura]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary Infarction]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,031: / Line 1,236: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[B cell lymphoproliferative disease|B cell lymphoproliferative disorder]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,045: / Line 1,261: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal disease]]
+! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute poststreptococcal glomerulonephritis|Acute Poststreptococcal Glomerulonephritis]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sarcoidosis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,055: / Line 1,279: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Legionella Infections|Legionella Infection]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,067: / Line 1,304: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! rowspan="9" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hematologic disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic lupus erythematosus]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,089: / Line 1,325: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia (CLL)]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rheumatoid arthritis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,099: / Line 1,342: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Relapsing polychondritis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-|-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Multiple myeloma|Multiple Myeloma]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,131: / Line 1,367: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypereosinophilic syndrome|Hypereosinophilic Syndrome]]
+! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Other
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Other
-!
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard'''
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]
+! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Variable-vessel vasculitis
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Behçet's disease|Behçet’s syndrome]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,162: / Line 1,406: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cogan syndrome|Cogan's syndrome]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,169: / Line 1,424: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Serum sickness|Serum Sickness]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''[[Red eye]], [[Hearing loss]], [[Vertigo]]'''
+|-
+! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Inflammatory bowel disease|Inflammatory Bowel Disease]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,185: / Line 1,449: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Whipple's disease]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,201: / Line 1,470: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sjögren's syndrome]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,215: / Line 1,495: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Idiopathic thrombocytopenic purpura|Idiopathic Thrombocytopenic Purpura]]
+! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Single-organ vasculitis
+! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary [[central nervous system]] [[vasculitis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Von Willebrand factor (vWF)|von Willebrand factor antigen (vWF)]]
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,223: / Line 1,513: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infectious disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Aspergillosis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,236: / Line 1,539: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[B cell lymphoproliferative disease|B cell lymphoproliferative disorder]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Histoplasmosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,257: / Line 1,560: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Herpes Simplex Encephalitis]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sarcoidosis]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,267: / Line 1,577: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+!
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+|-
+! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic diseases|Systemic disease]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eclampsia]]
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
@@ Line 1,279: / Line 1,603: @@
 ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Legionella Infections|Legionella Infection]]
+! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Fibromuscular dysplasia]]<ref name="pmid17555581" />
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Transforming growth factor β|Transforming growth factor β (TGF-β)]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Alternating [[stenosis]] and [[Dilatation|dilatations]] in [[CT angiography]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stenosis]] in the [[renal arteries]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Luminal narrowing alternating with [[dilatation]] (Beads sign)
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Focal [[concentric]], long-segment [[tubular]] [[stenosis]] or outpouching in [[MRA]]
-!
+!Fibrodysplastic changes, [[Collagen]] deposition
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Digital subtraction angiography|Digital subtraction angiography (DSA)]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
+! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Spontaneous coronary artery dissection|Spontaneous coronary artery dissection (SCAD)]]
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic lupus erythematosus]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rheumatoid arthritis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Relapsing polychondritis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache
-! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit
-! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker
-! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC
-! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Other
-! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Other
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology
-! style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard'''
-! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
-|-
-! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Variable-vessel vasculitis
-! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Behçet's disease|Behçet’s syndrome]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cogan syndrome|Cogan's syndrome]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Inflammatory bowel disease|Inflammatory Bowel Disease]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Whipple's disease]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sjögren's syndrome]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Single-organ vasculitis
-! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary [[central nervous system]] [[vasculitis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infectious disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Aspergillosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Histoplasmosis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Herpes Simplex Encephalitis]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic diseases|Systemic disease]]
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eclampsia]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-|-
-! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Fibromuscular dysplasia|Fibromuscular Dysplasia]]
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-!
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
-! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 |-
 |}

Differentiating vasculitis from other diseases: Difference between revisions

Revision as of 20:35, 29 March 2018

Overview

Differential Diagnosis

References

Navigation menu

Search